Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling

Exp Mol Med. 2010 Feb 28;42(2):143-54. doi: 10.3858/emm.2010.42.2.016.


TNF-alpha is a major cytokine involved in inflammatory bowel disease (IBD). In this study, water extract of Grifola frondosa (GFW) was evaluated for its protective effects against colon inflammation through the modulation of TNF-alpha action. In coculture of HT-29 human colon cancer cells with U937 human monocytic cells, TNF-alpha-induced monocyte adhesion to HT-29 cells was significantly suppressed by GFW (10, 50, 100 micg/ml). The reduced adhesion by GFW correlated with the suppressed expression of MCP-1 and IL-8, the major IBD-associated chemokines. In addition, treatment with GFW significantly suppressed TNF-alpha-induced reactive oxygen species production and NF-kappaB transcriptional activity in HT-29 cells. In differentiated U937 monocytic cells, LPS-induced TNF-alpha production, which is known to be mediated through NF-kappaB activation, was significantly suppressed by GFW. In an in vivo rat model of IBD, oral administration of GFW for 5 days (1 g/kg per day) significantly inhibited the trinitrobenzene sulfonic acid (TNBS)-induced weight loss, colon ulceration, myeloperoxidase activity, and TNF-alpha expression in the colon tissue. Moreover, the effect of GFW was similar to that of intra-peritoneal injection of 5-aminosalicylic acid (5-ASA), an active metabolite of sulfasalazine, commonly used drug for the treatment of IBD. The results suggest that GFW ameliorates colon inflammation by suppressing production of TNF-alpha as well as its signaling through NF-kappaB leading to the expression of inflammatory chemokines, MCP-1 and IL-8. Taken together, the results strongly suggest GFW is a valuable medicinal food for IBD treatment, and thus may be used as an alternative medicine for IBD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion / drug effects
  • Cell Adhesion / immunology
  • Cell Extracts / administration & dosage
  • Cell Extracts / pharmacology*
  • Chemokine CCL2 / biosynthesis
  • Chemokine CCL2 / genetics
  • Coculture Techniques
  • Colon / drug effects
  • Colon / metabolism*
  • Colon / pathology
  • Grifola
  • HT29 Cells
  • Humans
  • Inflammatory Bowel Diseases / chemically induced
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / pathology
  • Inflammatory Bowel Diseases / physiopathology
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / genetics
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Monocytes / drug effects*
  • Monocytes / metabolism
  • Monocytes / pathology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Peroxidase / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Stomach Ulcer
  • Transcription, Genetic / drug effects
  • Trinitrobenzenesulfonic Acid / administration & dosage
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / genetics
  • U937 Cells
  • Weight Loss


  • CCL2 protein, human
  • Cell Extracts
  • Chemokine CCL2
  • Interleukin-8
  • NF-kappa B
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Trinitrobenzenesulfonic Acid
  • Peroxidase